Introduction {#s1}
============

Tissue-specific gene expression plays a fundamental role in multi-cellular biology. In general, about 100 to 200 signature genes are expressed in a specific tissue. A detailed understanding of the tissue-specific pattern of gene expression can help elucidate the molecular mechanisms of tissue development, gene function, and transcriptional regulation of biological processes [@pone.0064483-Niehrs1]. Tissue-specific transcript analysis can indicate novel functions of known and unknown genes. The expression of tissue-specific genes can also be used as an indicator for many complex diseases. Examples include the tissue-specific expression of insulin signaling-related genes in diabetes, the stroma-tumor interaction-related genes in cancer, and the tissue-specific expression of mutant *IKBKAP* (inhibitor of kappa light polypeptide enhancer in B cells, kinase complex-associated protein) gene in Familial Dysautonomia [@pone.0064483-Slaugenhaupt1].

Microarrays are established technologies that can provide large-scale gene expression data through measurements of transcript abundance in various tissues. Various tissue-specific expression information is available in many databases including GEO [@pone.0064483-Barrett1], ArrayExpress [@pone.0064483-Parkinson1], TiGER [@pone.0064483-Liu1], BODYMAP [@pone.0064483-Ogasawara1] and BioGPS [@pone.0064483-Su1]. The Gene Expression Omnibus (GEO) database contains gene expression profiles derived from curated GEO DataSets (GDS), which store originally submitted records obtained from common commercial arrays (Affymetrix, Agilent, Illumina, or Nimblegen). The GDS contains several thousand gene expression profiles with 4 to 70 microarrays per profile and 12,000 to 30,000 genes per microarray, comparing diverse tissues and cells of human and mouse origins under various experimental conditions.

The GeneAtlas data on the website (<http://biogps.org>) provide baseline expression data for the expression patterns of thousands of predicted genes, as well as known and poorly characterized genes, across more than 60 murine tissues, and over 100 human tissues. However, the data from microarray experiments represent only a starting point toward understanding the microarray-derived measurements of differential gene expression. Although huge amounts of useful data are available to scientists, there is a lack of a follow-up strategy to integrate and use these data to identify novel sets of genes that are important for each field of study. There have been no attempts to integrate these valuable databases to identify novel sets of tissue-specific genes that might have important functions in tissue growth and development.

The objective of the current study was to identify and evaluate novel tissue-specific genes across the human and mouse by performing an analysis of microarray databases and semi-quantitative PCR analysis. In the current study, we developed a unique approach to generate accurate predictions of tissue-specific genes by comparing expression profiles for various tissues across the human and mouse. The semi-quantitative PCR analysis confirmed the accuracy of our predictions. We identified 59 genes across 6 human and mouse adult tissues: 10 kidney-specific, 11 liver-specific, 11 lung-specific, 11 heart-specific, 8 muscle-specific, and 8 adipose-specific. Among them we discovered 3 novel tissue-specific genes: AMDHD1 (amidohydrolase domain containing 1) in the liver, PRUNE2 (prune homolog 2) in the heart, and ACVR1C (activin A receptor, type IC) in the adipose tissue. The processes in which PRUNE2 and AMDHD1 may participate were predicted according to the GEO profiles. Further studies have shown that ACVR1C is adipose tissue-specific and adipocyte-specific in adipose tissue, and can be used as an adipocyte developmental marker. Our approach provides a novel method for identifying novel tissue-specific genes and predicting functions in which they may be involved.

Methods {#s2}
=======

Data Sources and Processing {#s2a}
---------------------------

The microarray expression profiles from 6 tissues (kidney, liver, lung, heart, muscle, and adipose) were derived from the GEO DataSet (GDS) in the NCBI web site: GDS3142 for mouse and GDS596 for human. Each tissue was represented by GEO samples (GSMs) from 2 to 4 subjects (human kidney: GSM18955 and GSM18956; human liver: GSM18953 and GSM18954; human lung: GSM18949 and GSM18950; human heart: GSM18951 and GSM18952; human muscle: GSM19013 and GSM19014; human adipose: GSM18975 and GSM18976; mouse kidney: GSM252083, GSM252084, and GSM252085; mouse liver: GSM252074, GSM252075, and GSM252076; mouse lung: GSM252080, GSM252081, and GSM252082; mouse heart: GSM252113, GSM252114, and GSM252115; mouse muscle: GSM252070, GSM252071, GSM252072, and GSM252073; mouse adipose: GSM252093, GSM252094, and GSM252095).

Tissue-specific genes were determined as follows: i) Gene expression values for each tissue in the GSM data (e.g., A and B in human kidney, C and D in human liver, and E and F in human lung) were averaged to obtain an average value \[e.g., (A+B)/2, (C+D)/2, and (E+F)/2\]; ii) To find tissue-specific genes (e.g., kidney-specific genes), the average values were divided by an average value of a target tissue {e.g., \[(C+D)/2\]/\[(A+B)/2\] and \[(E+F)/2\]/\[(A+B)/2\] }and then averaged to obtain one representative value \<e.g., {\[(C+D)/2\]/\[(A+B)/2\]+\[(E+F)/2\]/\[(A+B)/2\]}/2\>. If the value is lower, it means that the kidney value \[(A+B)/2\] and kidney-specificity is higher; iii) Averaged values were sorted in ascending order representing a lower value with a higher tissue-specific expression; iv) This method also shows relative gene expression ratios in other non-target tissues {e.g., \[(C+D)/2\]/\[(A+B)/2\] and \[(E+F)/2\]/\[(A+B)/2\]};v) An alternative method for finding tissue-specificity is to divide an average gene expression value for a target tissue \[e.g., (A+B)/2 for kidney\] by an average of averages of gene expression values in other tissues \<e.g., {\[(C+D)/2\]+\[(E+F)/2\]}/2\>, and sort the resulting values in descending order. Highly ranked genes shown in both human and mouse were selected for further analysis ([Figure 1](#pone-0064483-g001){ref-type="fig"} shows the process of selecting kidney-specific genes; [Table S1](#pone.0064483.s001){ref-type="supplementary-material"} shows the Excel spreadsheets of tissue-specific genes in selected tissues). The rank for each gene in each tissue is shown in [Table S1](#pone.0064483.s001){ref-type="supplementary-material"}.

![Steps for selecting kidney-specific genes.\
Tissue-specific genes were determined as follows: i) Gene expression values for each tissue were averaged; ii) The averaged values were divided by an averaged value for kidney; iii) The results were averaged and sorted in ascending order with a lower value representing higher tissue-specific expression. Highly ranked genes with lower values are candidates for kidney-specific genes; iv) An alternative method for finding tissue-specificity is to divide an average gene expression value for kidney by an average of averages of gene expression values in other tissues.](pone.0064483.g001){#pone-0064483-g001}

Animal Use and Ethics Statement {#s2b}
-------------------------------

All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) at The Ohio State University. All experiments were performed in accordance with the Prevention of Cruelty to Animals Act (1986). All mice were raised in a mouse housing facility at the Ohio State University and fed *ad libitum*. Mice were euthanized by CO2 inhalation followed by cervical dislocation. White adipose tissue (WAT), brown adipose tissue (BAT), liver, muscle, heart, lung, spleen, and kidney were harvested from 3-month-old mice to isolate total RNAs (n = 3). Mouse inguinal adipose tissue was collected from 1-month-old FVB mice [@pone.0064483-Li1].

Differentiation of Preadipocytes {#s2c}
--------------------------------

The 3T3-L1 preadipocytes were differentiated to adipocytes as previously described [@pone.0064483-Li1]. The 3T3-L1 preadipocytes (American Type Culture Collection, Manassas, VA, USA) were cultured in DMEM culture media (Invitrogen, Carlsbad, CA, USA) containing 10% fetal bovine serum (Invitrogen) and the mixture solution of penicillin and streptomycin (Pen Strep; Invitrogen). The preadipocytes were maintained and grown to confluence at 37°C in 5% CO~2~. After 2 d post-confluence (Day 0), differentiation of 3T3-L1 preadipocytes to adipocytes was induced by treating the preadipocytes for 2 d with a differentiation media, which contains 1 µM dexamethasone, 0.25 mM isobutylmethylxanthine, and 1 µg/ml insulin (Sigma-Aldrich Co., St. Louis, MO, USA) additionally in the culture media. Two days after induction (Day 2), the differentiation media was changed to the insulin media, which was composed of 1 µg/ml insulin in the culture media, for the next 2 d. Two days later (Day 4), the insulin media was changed to the DMEM culture media for another 4 d and the media was changed every 2 d. Total RNA was isolated from the 3T3L1 adipocytes at d 0, 2, 4, 6, and 8 post-differentiation.

cDNA Synthesis and PCR Analysis {#s2d}
-------------------------------

Mouse total RNA was isolated from kidney, liver, lung, heart, muscle, and adipose tissue of adult mice using Trizol reagent (Invitrogen; [@pone.0064483-Li1]). Adult human RNAs from kidney, liver, lung, heart and muscle were purchased from Agilent Technologies (Santa Clara, CA, USA) and adult human RNA from adipose tissue was bought from Clontech Laboratories (Mountain View, CA, USA). Stromal vascular (SV) and fat cell (FC) fractionation were isolated according to procedures described previously [@pone.0064483-Li1], [@pone.0064483-Deiuliis1], [@pone.0064483-Deiuliis2]. In brief, the adipose tissue was incubated with 3.2 mg/ml collagenase II (Sigma-Aldrich) in DMEM media for 1 h at 37°C in a vigorous shaker to separate each cell. The digested adipose tissue was filtered to remove large cell masses, and then centrifuged for 5 min at 500×g to isolate the floating FC fraction from the pellet of the SV fraction. Both SV and FC fractions were gathered for RNA isolation (n = 3).

RNA was reverse-transcribed to cDNA using moloney murine leukemia virus reverse transcriptase (Invitrogen). The PCR reaction consisted of 1 µL of cDNA, 0.5 µL of 10 mM deoxynucleoside triphosphate mix (dNTP), 2.5 µL of 10×ThermopolII (Mg-free) reaction buffer, 0.5 µL of 100 mM MgSO~4~, 0.5 nM of each of the forward and reverse primers, 0.125 µL of Taq DNA polymerase (Thermo Fisher Scientific, Waltham, MA, USA), and nuclease-free water up to 25 µL. The cycling parameters were 95°C for 5 min, followed by 25 to 30 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 40 s with a final elongation at 72°C for 10 min. A 1% agarose gel was used to check PCR amplification.

For cDNA reverse transcription, 1 µg of total RNA, oligo dT, and M-MLV reverse transcriptase (Invitrogen) were used. The conditions for reverse transcription were 65°C for 5 min, 37°C for 50 min, and 70°C for 15 min. Quantitative real-time PCR was performed as described previously [@pone.0064483-Li1], [@pone.0064483-Li2] using AmpliTaq Gold polymerase (Applied Biosystems, Foster City, CA, USA) and SYBR green I as a detection dye. The sequences of primers for real-time PCR of cyclophilin (cyc), delta-like 1 (DLK1), fatty acid binding protein 4 (FABP4) and stearoyl-CoA desaturase-1 (SCD1) were as described previously [@pone.0064483-Li1], [@pone.0064483-Li2]. All other primers used are listed in [Table 1](#pone-0064483-t001){ref-type="table"}. The mRNA expression of each gene was normalized to mRNA expression of cyclophilin, which was used as an internal control.

10.1371/journal.pone.0064483.t001

###### Primer sequences for PCR amplification.

![](pone.0064483.t001){#pone-0064483-t001-1}

  Gene name       Primer sequence (5′--3′)      Gene name       Primer sequence (5′--3′)
  ----------- -------------------------------- ----------- ----------------------------------
  SCGB1A1       h-f: CCACCAGACTCAGAGACGGAAC      SLC22A2      h-m-f: GTCAGCAAAGCAGGCTGGTTA
                  h-r: TGGGCGTGGACTCAAAGCA                     h-m-r: GCATGATGAGGCCCTGGTA
               m-f: ACAACATCACCCCACATCTACAGAC     PDZK1     h-m-f: CTGGTCAGAAAGAGTGGGAATTCA
                 m-r: CAAAGAGGAAGGAGGGGTTGG                  h-m-r: TTTCAACCACTTCCTCATGGCT
  SFTPB          h-m-f: ACCCTCTGCTGGACAAGCT      SLC12A3    h-m-f: ATCATTTCCAACTTCTTCCTCTGC
                 h-m-r: AGCCAGGCACTGGCAGAT                  h-m-r: GGTAGTTCTTGATGTGGTCTTCCAC
  SFTPC        h-m-f: AGCAAAGAGGTCCTGATGGAGA      SPP1         h-f: GAAAGCCATGACCACATGGA
                  h-m-r: CCAGTGGAGCCGATGGA                     h-r: TGGGTTTCAGCACTCTGGTCA
  CLIC3          h-m-f: GCGGCTCTTCATGGTCCT                     m-f: GAAAGCCATGACCACATGGA
                h-m-r: CAGGTAGCTGTCCAGCCTGG                  m-r: ACTATCGATCACATCCGACTGATC
  SLC34A2       h-m-f: GCAGGCATGACCTTCATCGT      SLC34A1     h-m-f: ATGCTCAACTCCCTGCTCAAGG
                h-m-r: CGAACCAGCGATACTTGGCA                   h-m-r: GCAAACCAGCGGTACTTGGC
  AGER           h-m-f: AACATCACAGCCCGGATTG       FXYD2       h-f: GGACGTGGACCCGTTCTACTATG
                h-m-r: GTCTCAGGGTGTCTCCTGGTC                   h-r: GGAGCTTCCTTCAGCCCAAG
  TNNT2         h-m-f: ATCCCCGATGGAGAGAGAGTG                   m-f: CTATGAAACCGTCCGCAAAGG
                    GCCACAGCTCCTTGGCCTTC                      m-r: GATGAGGCTACACATGCTCCTCA
  FHOD3        h-m-f: AGACCAGAGGGAAGATGATCAC     AMDHD1      h-m-f: CCTCGAGCCAGGAAGATGTTAG
                h-m-r: CAGGGCTCTGGCTTCTTCTGG                 h-m-r: TCAATTAATTCATGATGGCCTCC
  NPPA          h-m-f: TAGAAGATGAGGTCATGCCCC      AMBP      h-m-f: CCTATGTGGTCCACACCAACTATG
                  GTCCTTGGTGCTGAAGTTTATTC                     h-m-r: GACTATGGGGAGATTGCAGGC
  PLN          h-m-f: AAAGTCCAATACCTCACTCGCTC     GNMT       h-m-f: CTTTGATGCTGTCATCTGCCTTG
                   GAAATGCCTCAGCAAGCACGTC                      h-m-r: CAGGACGCTGTGCTGGCAC
  MYH6          h-m-f: TCCGCAAACAGCTGGAGGTG        HPX      h-m-f: CGCTACTACTGCTTCCAGGGTAAC
               h-m-r: CTTCTGGTTGATGAGGCTGGTG                  h-m-r: GCCTCCCTTTGTCAGGAAGAC
  CSRP3        h-m-f: CAAAATGTGGAGCCTGTGAAAAG      ALB       h-m-f: TGCAACACAAAGATGACAACCC
                h-m-r: CTCTTCCCACAGATGGCACAG                   h-m-r: TGCCCAGGAAGACATCCTT
  RYR2          h-m-f: AGGTCTCCACTTCTTCTGTGG      APOA1      h-m-f: CGGCAGAGACTATGTGTCCCAG
                h-m-r: CCAGGCTAGGTAGAGGAAGGA                  h-m-r: CTTCTGGCGGTAGAGCTCCA
  ACTN3          h-f: GGCTCTCTGGAGGAGCAGATG      SLC27A5      h-m-f: TCCTGCGGTACTTGTGTAAC
                h-r: CTCGGGTCAGTACCTGGTTCTC                   h-m-r: TCGAACTGCACCAGCTCAAAG
                 m-f: CCCAGCCGTGACCAGACACTG        FGG       h-m-f: GGCTGGGAAATGATGAGAAGAT
                 m-r: TTGGGGTCCACCATGGTCATG                  h-m-r: CACAGTTGCCTTCAAACTTATC
  PRUNE2       h-m-f: CTACCAGATGATTGACAGACGG       CYC         h-f: CTCCTTTGAGCTGTTTGCAG
               h-m-r: GATGATGCTCTCTGGAATGTGG                    h-r: CACCACATGCTTGCCATCC
  ACVR1C        h-m-f: GTTTGCCTCCTGTCCATAGC                   m-f: AGCACTGGAGAGAAAGGATTTGG
                h-m-r: GGTTCCCACTTTAGGATTCTG                  m-r: TCTTCTTGCTGGTCTTGCCATT

Statistical Analysis {#s2e}
--------------------

Statistical analysis for the tissue distribution of gene expression was performed by a mixed ANOVA model (tissues showing significant expression at α = 0.05 vs. other tissues) followed by a Fisher's protected least significant difference test. Analysis of SV and FC fraction was performed using the Student's *t* test at *P*\<0.05. Differences among the developmental time points were compared by one-way ANOVA followed by the Tukey's post hoc test (*P*\<0.05). To compare the difference between a control and an experimental group from GEO DataSets (GDS), Student's *t* test was conducted (*P*\<0.05). In addition, one-way ANOVA followed by Tukey's post hoc test (*P*\<0.05) was performed to compare multiple treatments from GDS. All statistical analyses were conducted using SAS software (version 9.2, SAS Institute Inc., Cary, NC, USA).

Results {#s3}
=======

Discovery of Tissue-Specific Genes {#s3a}
----------------------------------

Twelve Excel spreadsheet files were generated for the kidney, liver, lung, heart, muscle, and adipose tissue specific expression in the human and mouse, respectively. By comparing top-rated genes across the human and mouse, 10 kidney, 11 liver, 11 lung, 11 heart, 8 muscle, and 8 adipose genes were selected. Names and ranks of selected genes, and ratios to an average of other tissues are provided in [Table S1](#pone.0064483.s001){ref-type="supplementary-material"}. These genes are significantly more highly expressed in certain tissues than in other tissues (*P*\<0.001) with few exceptions ([Table 2](#pone-0064483-t002){ref-type="table"}, [3](#pone-0064483-t003){ref-type="table"}, [4](#pone-0064483-t004){ref-type="table"}, [5](#pone-0064483-t005){ref-type="table"}, [6](#pone-0064483-t006){ref-type="table"}, [7](#pone-0064483-t007){ref-type="table"}, [8](#pone-0064483-t008){ref-type="table"}, [9](#pone-0064483-t009){ref-type="table"}, [10](#pone-0064483-t010){ref-type="table"}, [11](#pone-0064483-t011){ref-type="table"}, [12](#pone-0064483-t012){ref-type="table"}, [13](#pone-0064483-t013){ref-type="table"}). The tissue-specific expressions of those genes were confirmed either by existing publications or by semi-quantitative PCR and gel-electrophoresis ([Figure 2](#pone-0064483-g002){ref-type="fig"}). Three novel tissue-specific genes discovered by our method included AMDHD1 in the liver, PRUNE2 in the heart and ACVR1C in the adipose tissue. Their tissue-specific expressions were confirmed by both semi-quantitative PCR and real-time PCR ([Figures 2](#pone-0064483-g002){ref-type="fig"}, [3A](#pone-0064483-g003){ref-type="fig"}, [4A](#pone-0064483-g004){ref-type="fig"}, and [5A](#pone-0064483-g005){ref-type="fig"}).

![Expression of adult human and mouse gene transcripts detected by PCR reaction and agarose gel electrophoresis.\
Lanes 1--6 contain PCR products from human and lanes 7--12 contain PCR products from mouse. Lanes 1 and 7: kidney, lanes 2 and 8: liver, lanes 3 and 9: lung, lanes 4 and 10: heart, lanes 5 and 11: muscle, and lanes 6 and 12: adipose. Housekeeping genes, human and mouse cyclophilin (cyc), serve as a loading control.](pone.0064483.g002){#pone-0064483-g002}

![AMDHD1 (amidohydrolase domain containing 1) mRNA expression.\
A, Real-time PCR for AMDHD1 mRNA tissue distribution. Total RNA were isolated from the white adipose tissue (WAT), brown adipose tissue (BAT), liver, muscle, heart, lung, spleen, and kidney of adult mice. The mRNA expression was measured by quantitative real-time reverse transcription PCR (qRT-PCR) (n = 3). The bar represents mean ± SEM. Statistical significance is indicated by \*\*\*(*P*\<0.001). Housekeeping gene cyclophilin (cyc) was used to normalize the mRNA expression. B--E, Analysis of microarray DataSets obtained from the NCBI website, which contains expression profiles for AMDHD1. B: GDS1729 (n = 5 per group), C: GDS1916 (n = 3 per group), D: GDS2577 (n = 3--4 per group), and E: GDS1517 (n = 5 per group). HNF4*α*: hepatocyte nuclear factor 4 alpha; dpc: days post conception; aph: after partial hepatectomy.](pone.0064483.g003){#pone-0064483-g003}

![PRUNE2 (prune homolog 2) mRNA expression.\
A, Real-time PCR for PRUNE2 mRNA tissue distribution. Total RNA were isolated from the white adipose tissue (WAT), brown adipose tissue (BAT), liver, muscle, heart, lung, spleen, and kidney of adult mice. The mRNA expression was measured by quantitative real-time reverse transcription PCR (qRT-PCR) (n = 3). The bar represents mean ± SEM. Statistical significance is indicated by \*\*\*(*P*\<0.001). Housekeeping gene cyclophilin (cyc) was used to normalize the mRNA expression. B--E, Analysis of microarray DataSets obtained from the NCBI website that contains expression profiles for PRUNE2. B: GDS2727 (n = 3 per group), C: GDS2746 (n = 6--8 per group), D: GDS651 (n = 11--15 per group), and E: GDS3673 (n = 5 per group). ERRα: estrogen-related receptor alpha; Lmna: lamin A/C.](pone.0064483.g004){#pone-0064483-g004}

![ACVR1C (activin A receptor, type IC) mRNA expression.\
A, Real-time PCR for ACVR1C mRNA tissue distribution. Total RNA were isolated from the white adipose tissue (WAT), brown adipose tissue (BAT), liver, muscle, heart, lung, spleen, and kidney of adult mice. The mRNA expression was measured by quantitative real-time reverse transcription PCR (qRT-PCR) (n = 3). The bar represents mean ± SEM. Statistical significance is indicated by \*\*\*(P\<0.001). Housekeeping gene cyclophilin (cyc) was used to normalize the mRNA expression. B and C, Analysis of microarray DataSets obtained from the NCBI website containing expression profiles for ACVR1C. B: GDS3135 (n = 4 per group) and C: GDS3665 (n = 5 per group). D--G, Relative expression of DLK1, FABP4, SCD1, and ACVR1C in the stromal-vascular (SV) and fat cell (FC) fractions from mouse inguinal adipose tissue. Each bar indicates mean and SEM (n = 5). Statistical significance by Student's t test is shown: \*, *P*\<0.05; \*\*, *P*\<0.01. The gene expression was normalized to cyclophilin (cyc) mRNA expression. H--J, Developmental regulation of ACVR1C during adipogenic differentiation of 3T3-L1 cells. The bar represents mean ± SEM (n = 3). Letters a and b show significant differences in gene expression among several time-points (day 0, 2, 4, 6, and 8) in adipocyte differentiation at *P*\<0.05. The mRNA abundance was measured by quantitative real-time reverse transcription PCR (qRT-PCR) and normalized to cyclophilin (cyc) mRNA.](pone.0064483.g005){#pone-0064483-g005}

10.1371/journal.pone.0064483.t002

###### Human kidney-specific gene expression values.

![](pone.0064483.t002){#pone-0064483-t002-2}

  Gene           Kidney           Liver          Lung           Heart          Muscle         Adipose     *P* value[a](#nt101){ref-type="table-fn"}
  --------- ----------------- -------------- ------------- --------------- --------------- ------------- -------------------------------------------
  GALNT11     1768650±25854    209850±77262   295450±8851   244800±68610    155500±30505    271400±4801                    \<.0001
  SLC22A6    2441850±177177    41900±13602     8250±350      56900±43807     73550±12452     8250±150                      \<.0001
  SLC22A8    4959550±860580    70850±13252    38800±10702    69900±29504    223350±60559    61700±29905                    \<.0001
  SLC22A2    1041350±175076    136550±57659   82700±32805    41450±4651     375600±112217   31350±11652                    \<.0001
  KL         1565900±114717    74350±53258    59600±7101     38500±27004    576700±214132   24950±19053                    \<.0001
  PDZK1       2576450±82362    90950±68260     9000±1500     72200±35005    451500±61209    48250±1850                     \<.0001
  SLC12A3     1107100±29805     45800±4801    19200±1600     50100±20903     130300±900     23800±10302                    \<.0001
  SPP1       6054550±271291    112100±35005   105000±2200    59100±10902    365750±275592   140150±550                     \<.0001
  SLC34A1     1566950±94764    268150±53958   90150±51358   142850±116768   129300±38306    60300±8701                     \<.0001
  FXYD2      11852250±272891   155850±39056   62500±33105   265050±171576   642700±59909    99750±46257                    \<.0001

*P* value represents the significance of gene expression in the human kidney compared to other tissues.

10.1371/journal.pone.0064483.t003

###### Mouse kidney-specific gene expression values.

![](pone.0064483.t003){#pone-0064483-t003-3}

  Gene        Kidney    Liver      Lung     Heart    Muscle   Adipose   *P* value[a](#nt102){ref-type="table-fn"}
  --------- ---------- -------- ---------- -------- -------- --------- -------------------------------------------
  GALNT11    3362±149   170±2     198±21    156±2    157±5    215±15                     \<.0001
  SLC22A6    1986±129   105±3     110±6     157±7    118±4     103±6                     \<.0001
  SLC22A8    1741±130    86±6      88±4     120±3     80±1     85±3                      \<.0001
  SLC22A2    1872±59    109±5      83±3      99±4     97±3     92±6                      \<.0001
  KL         1914±65     76±1      76±6      93±3     85±1     72±3                      \<.0001
  PDZK1      4070±129   530±49     98±2     106±3    106±4     111±5                     \<.0001
  SLC12A3    1987±249   136±2     120±3     143±11   120±4     115±6                     \<.0001
  SPP1       4933±273   435±67   1037±210   104±4    145±12   104±18                     \<.0001
  SLC34A1    7269±107   102±3      94±8     101±10    92±3     89±4                      \<.0001
  FXYD2      9786±153    76±2     99±15     113±4    106±2    215±12                     \<.0001

*P* value represents the significance of gene expression in the mouse kidney compared to other tissues.

10.1371/journal.pone.0064483.t004

###### Human liver-specific gene expression values.

![](pone.0064483.t004){#pone-0064483-t004-4}

  Gene          Kidney             Liver             Lung           Heart          Muscle         Adipose     *P* value[a](#nt103){ref-type="table-fn"}
  --------- --------------- ------------------- -------------- --------------- --------------- ------------- -------------------------------------------
  HAMP       171900±42806    11845400±1589440    25500±20103    690200±445667   370050±119868   54150±15252                    \<.0001
  AHSG        77800±44407    24651250±4147376     10550±150     189200±33805    318450±76662    33700±13702                    \<.0001
  AMBP        29800±14102    44128150±5392864     9100±3601      16750±4151      65750±7251     21050±10552                    \<.0001
  HPX        196050±100465   21364500±2278144    110450±33855   102750±33455    403000±131520   56350±3050                     \<.0001
  ALB         511500±6101     32913750±61559      50450±9351     91800±88613    114300±38006    53000±11602                    \<.0001
  APOA1       74300±2600     50972350±10240696   45900±11902    349250±121768   309150±136971   52800±25004                    \<.0001
  SLC27A5     58150±12552     11243300±360854    65400±25504     38300±9101     105450±13052    35000±7401                     \<.0001
  FGG         53400±49207     10354250±496925    74250±24254    135350±28454    333450±64160    54100±21403                    \<.0001
  GNMT        89750±70861     4526150±933091      12350±1750     44200±30205    243850±135070   20000±8101                     \<.0001
  MAT1A       46600±12902     8485900±318148      26350±2950     38750±14052    301400±41106    43650±8751                     \<.0001

*P* value represents the significance of gene expression in the human liver compared to other tissues.

10.1371/journal.pone.0064483.t005

###### Mouse liver-specific gene expression values.

![](pone.0064483.t005){#pone-0064483-t005-5}

  Gene       Kidney     Liver     Lung    Heart    Muscle   Adipose   *P* value[a](#nt104){ref-type="table-fn"}
  --------- -------- ----------- ------- -------- -------- --------- -------------------------------------------
  HAMP        82±2    6092±1249   122±4   121±16    83±3     79±4                      \<.0001
  AHSG        93±1    8121±414    92±8    124±3     96±2     94±4                      \<.0001
  AMBP        94±5    7279±204    79±4    101±2     89±1     82±4                      \<.0001
  HPX         84±3    9046±350    93±5    100±1     98±3     84±1                      \<.0001
  ALB        183±3    16668±614   106±7   139±10   120±8     142±7                     \<.0001
  APOA1       91±4    14910±361   86±9    127±4    103±3     88±1                      \<.0001
  SLC27A5     84±4    5640±335    87±8    115±3     94±5     80±3                      \<.0001
  FGG        191±5    9792±373    81±1     96±4     87±4     75±4                      \<.0001
  GNMT       485±6    9337±214    181±6   216±10   182±11    115±9                     \<.0001
  MAT1A       76±2    4738±705    116±5    89±2     78±2     68±2                      \<.0001
  AMDHD1      82±2    1612±126    68±6     82±3     69±3     67±4                      \<.0001

*P* value represents the significance of gene expression in the mouse liver compared to other tissues.

10.1371/journal.pone.0064483.t006

###### Human lung-specific gene expression values.

![](pone.0064483.t006){#pone-0064483-t006-6}

  Gene          Kidney          Liver             Lung             Heart          Muscle         Adipose      *P* value[a](#nt105){ref-type="table-fn"}
  --------- --------------- -------------- ------------------ --------------- --------------- -------------- -------------------------------------------
  CLDN5      247000±52608    245800±18503    3249550±98165     634400±200330   572600±375857    54650±8451                     \<.0001
  CLDN18     158500±80912    248750±25154    2896050±202881    520000±331950   643050±209982   113450±19153                    \<.0001
  LPCAT1     212500±131420   49550±19953     1304850±440417     27050±1650      105200±5201    90550±64060                     \<.001
  MUC1       1190450±33755    34900±1400     3937250±418013     48050±30255    314650±164475   47250±14852                     \<.0001
  SCGB1A1    157000±97015    131700±80312    8461200±606492    192650±121068   459000±116518   92700±16402                     \<.0001
  SMAD6      130100±40306    48700±18203     770000±236136     193750±67260     85350±12552     23200±3901                     \<.001
  SFTPB      130800±16002    112700±76812   18122550±2916290   128500±49708    335300±18903    143050±29955                    \<.0001
  SFTPC       71700±3601      72400±9501    28720600±2420766    43900±8501      112150±8951     24450±3651                     \<.0001
  AGER        54700±15702     17150±5751     1179650±770166     52950±19353     87900±21303    70850±55658                      \<.05
  CLIC3       32700±16302     23050±5351     1270200±311047     40600±14802    108600±71411    81950±13252                     \<.0001
  SLC34A2    252100±20203    219050±89864    2808200±206331    247100±171326   711800±399460    61950±5451                     \<.0001

*P* value represents the significance of gene expression in the human lung compared to other tissues.

10.1371/journal.pone.0064483.t007

###### Mouse lung-specific gene expression values.

![](pone.0064483.t007){#pone-0064483-t007-7}

  Gene       Kidney   Liver      Lung      Heart    Muscle   Adipose   *P* value[a](#nt106){ref-type="table-fn"}
  --------- -------- -------- ----------- -------- -------- --------- -------------------------------------------
  CLDN5      196±8    186±24   3131±327    259±30   227±5    721±98                     \<.0001
  CLDN18      92±2    100±3    2162±188    113±10    88±3     82±2                      \<.0001
  LPCAT1     179±7    147±9    2681±141    190±7    159±5    289±31                     \<.0001
  MUC1       198±23   102±4     916±33     127±4    102±7     95±6                      \<.0001
  SCGB1A1     92±1     73±3    16192±411   107±4     79±2     86±9                      \<.0001
  SMAD6      165±5    134±5    1725±207    185±5    150±11   242±43                     \<.0001
  SFTPB      146±6    148±14   8236±493    222±4    147±14   148±16                     \<.0001
  SFTPC      100±5    105±4    17295±341   142±4     98±1     94±2                      \<.0001
  AGER       108±4     99±3    10701±129   218±8    140±7     118±5                     \<.0001
  CLIC3      154±4     95±3     1355±23     93±2     96±8     98±4                      \<.0001
  SLC34A2    147±7    134±9    5913±238    265±17   137±11    104±9                     \<.0001

*P* value represents the significance of gene expression in the mouse lung compared to other tissues.

10.1371/journal.pone.0064483.t008

###### Human heart-specific gene expression values.

![](pone.0064483.t008){#pone-0064483-t008-8}

  Gene         Kidney          Liver           Lung            Heart            Muscle         Adipose      *P* value[a](#nt107){ref-type="table-fn"}
  -------- --------------- -------------- -------------- ----------------- ---------------- -------------- -------------------------------------------
  FHL2      448350±147472   149000±91214   270350±7151    10829800±196430   996650±208782    545000±8801                     \<.0001
  HSPB7      619350±7951    218500±41206   349200±7201    16034200±279242   4024050±402711   776550±73761                    \<.0001
  MYOZ2      10800±5901      10900±3501      7650±550      1594350±58059     1238400±3501     6000±2200                      \<.0001
  TNNT2     156200±14402    108600±35405    46200±3601    9868550±1550184   423300±216733    113600±47107                    \<.0001
  FHOD3     285850±26454    36500±11702    34850±17253      817700±2100      171100±65210    47300±36405                     \<.0001
  PLN        37900±16302    40200±14302     14900±7701    1052750±251388    503800±348953     15950±2550                     \<.005
  MYH6       17600±2700      28700±4801    53050±15452    5613450±320798    1098450±264690    12700±7001                     \<.0001
  CSRP3      12150±4151      11600±2600      5300±400     5745250±515928    2571250±283193    8150±1850                      \<.0001
  NPPA      872650±221483   182900±79512   138900±74211   5658450±205681    2447950±762865   336900±52408                    \<.0001
  RYR2       72050±61359     28600±5401    20250±12952     291400±22103      99800±10502      10450±3951                     \<.0005
  PRUNE2    126700±42006    71650±20053    16850±12052     127800±46207      86450±36956     255800±8601                      \<.5

*P* value represents the significance of gene expression in the human heart compared to other tissues.

10.1371/journal.pone.0064483.t009

###### Mouse heart-specific gene expression values.

![](pone.0064483.t009){#pone-0064483-t009-9}

  Gene      Kidney   Liver    Lung       Heart       Muscle    Adipose   *P* value[a](#nt108){ref-type="table-fn"}
  -------- -------- ------- --------- ------------ ---------- --------- -------------------------------------------
  FHL2      279±7    140±5    173±6     8829±429     161±2      146±7                     \<.0001
  HSPB7      94±1    97±7    154±16     4441±118    1016±181    116±1                     \<.0001
  MYOZ2      80±3    96±2    193±14     8934±199    2157±145    82±1                      \<.0001
  TNNT2      74±4    79±4    422±27    16112±248     113±5      66±2                      \<.0001
  FHOD3     346±22   82±2     81±4      1353±58      421±36     75±10                     \<.0001
  PLN       102±3    75±8     185±8    14565±615     112±8      86±9                      \<.0001
  MYH6       71±2    73±2    839±124   19317±1430     83±2      87±12                     \<.0001
  CSRP3      86±2    411±5    247±8     8180±256    1294±176    86±0                      \<.0001
  NPPA       77±4    88±7    261±19     4431±361      83±3      80±2                      \<.0001
  RYR2       70±1    69±3     128±6     2889±51       74±3      68±2                      \<.0001
  PRUNE2     72±1    77±3     74±0       215±26       85±1      83±2                      \<.0001

*P* value represents the significance of gene expression in the mouse heart compared to other tissues.

10.1371/journal.pone.0064483.t010

###### Human muscle-specific gene expression values.

![](pone.0064483.t010){#pone-0064483-t010-10}

  Gene         Kidney          Liver           Lung           Heart            Muscle          Adipose      *P* value[a](#nt109){ref-type="table-fn"}
  -------- --------------- -------------- -------------- --------------- ------------------ -------------- -------------------------------------------
  MYOT       12900±6001      19500±7601    17250±12752     92450±35755     5427150±568736     14050±4651                     \<.0001
  TNNC2      200500±7901    85800±14002    139350±32055    81450±13252    72503600±4693109   64650±21753                     \<.0001
  TNNI2      40300±8301      25100±5901     28150±7951      43850±450     25906100±111517     22500±9601                     \<.0001
  TNNT3     220450±83863    228450±94964   161100±14102   565100±373356   11062700±366455    149900±32805                    \<.0001
  ACTN3     221850±24654    198850±90564   166450±15552   256300±87213     7269400±844828    163550±40656                    \<.0001
  MYBPC1    179500±64710    158700±64710   57750±10352    279550±101765    20410650±63360    113800±3100                     \<.0001
  MYBPC2     16600±3701      24550±8851      6800±100      50450±5851     12523950±251088     14650±6751                     \<.0001
  MYOZ1     311100±176027   238550±67760   180600±6901    372150±141771   15847500±217533    148900±12202                    \<.0001

*P* value represents the significance of gene expression in the human muscle compared to other tissues.

10.1371/journal.pone.0064483.t011

###### Mouse muscle-specific gene expression values.

![](pone.0064483.t011){#pone-0064483-t011-11}

  Gene      Kidney   Liver     Lung    Heart     Muscle     Adipose   *P* value[a](#nt110){ref-type="table-fn"}
  -------- -------- -------- -------- -------- ----------- --------- -------------------------------------------
  MYOT       66±1     65±2     63±0    836±14   7300±174     64±3                      \<.0001
  TNNC2      82±3     94±7     80±3    135±3    15148±298    90±2                      \<.0001
  TNNI2      89±4     94±8    105±13   109±4    15552±388    92±4                      \<.0001
  TNNT3      79±4    101±11    90±4     83±4    14045±248    83±3                      \<.0001
  ACTN3      92±3    107±5    101±20   119±4    11726±449    150±8                     \<.0001
  MYBPC1     89±2     95±3     85±2     97±3    3414±295     87±4                      \<.0001
  MYBPC2     83±2     82±4    100±2    183±13   9194±118     94±5                      \<.0001
  MYOZ1     139±6    161±6    157±50   214±14    7523±84    145±11                     \<.0001

*P* value represents the significance of gene expression in the mouse muscle compared to other tissues.

10.1371/journal.pone.0064483.t012

###### Human adipose-specific gene expression values.

![](pone.0064483.t012){#pone-0064483-t012-12}

  Gene         Kidney           Liver           Lung            Heart           Muscle           Adipose        *P* value[a](#nt111){ref-type="table-fn"}
  -------- --------------- --------------- --------------- --------------- ---------------- ------------------ -------------------------------------------
  RETN       59850±32055     86150±42056    437450±156374   174450±100065    211200±89313      73500±32705                        \<.5
  ADIPOQ    173600±64710    141750±17753     34000±17103    393850±11152     299050±41256    10250050±1283044                    \<.0001
  LEP        13250±3351       8900±400        8950±1250      26550±5151      78650±15952        24350±2450                         \<1
  PPARG      42850±7951      35750±14352     80400±21503     22600±7001       84600±1400       917150±14252                      \<.0001
  CIDEC     546300±145022   787350±256989   400000±153723   894150±271191   1235150±349403   10546600±390859                     \<.0001

*P* value represents the significance of gene expression in the human adipose tissue compared to other tissues.

10.1371/journal.pone.0064483.t013

###### Mouse adipose-specific gene expression values.

![](pone.0064483.t013){#pone-0064483-t013-13}

  Gene      Kidney    Liver      Lung    Heart    Muscle     Adipose    *P* value[a](#nt112){ref-type="table-fn"}
  -------- -------- ---------- -------- -------- --------- ----------- -------------------------------------------
  RETN      168±13    136±2     240±8    190±18   254±44    11518±177                    \<.0001
  ADIPOQ    177±39     67±0     355±30   123±10   830±177   15125±409                    \<.0001
  LEP        74±2      80±1      75±2     88±4    105±10    1719±137                     \<.0001
  PPARG     108±3     168±24    148±4    172±16    135±8    2016±159                     \<.0001
  CIDEC      83±6      88±7     132±4     82±5    123±12    5175±484                     \<.0001
  CCDC80    146±2     191±10    362±2    734±34   409±46    6447±167                     \<.0001
  DGAT2     739±27   1252±158   213±8    727±29   330±16    4503±922                     \<.0001
  ACVR1C     58±2      61±2      63±2     60±2     68±2      776±208                     \<.0001

*P* value represents the significance of gene expression in the mouse adipose tissue compared to other tissues.

Regulation of Novel Gene Expression Under Different Physiological Conditions and Disease Models {#s3b}
-----------------------------------------------------------------------------------------------

Gene expression under different physiological conditions and disease models was investigated using GEO profiles to help understand potential functions of the novel genes. The GEO profiles provided information to predict the function of AMDHD1 in the liver. GDS1729 in the GEO Profiles shows that microRNA miR-122 antisense inhibits the expression of AMDHD1 in the liver ([Figure 3B, *P*](#pone-0064483-g003){ref-type="fig"}\<0.01). The miR-122 down-regulates target mRNAs to establish tissue-specific gene expression patterns. The decreased expression of AMDHD1 in miR-122 treated liver indicated that AMDHD1 is one of the target genes of miR-122 and is involved in liver development and formation. GDS1916 shows that the expression of AMDHD1 is decreased significantly when hepatocyte nuclear factor 4 alpha (HNF4*α*) is deleted ([Figure 3C, *P*](#pone-0064483-g003){ref-type="fig"}\<0.01). HNF4α is a promoter for the expression of hundreds of metabolism-related genes in the liver. The co-expression of AMDHD1 and HNF4α indicates that AMDHD1 may be involved in hepatogenesis. The relatively greater expression of AMDHD1 in the regenerating liver compared to the developing liver indicates the role of AMDHD1 in renewal and repair of the liver (GDS2577; [Figure 3D, *P*](#pone-0064483-g003){ref-type="fig"} *\<*0.05). Expression of AMDHD1 in control mice is not influenced by a low fat, high carbohydrate diet, whereas SCD1 null mice treated with a low fat, high carbohydrate diet have significantly decreased expression of AMDHD1 (GDS-1517; [Figure 3E, *P*](#pone-0064483-g003){ref-type="fig"}\<0.05). Because SCD1 is the rate-limiting enzyme that catalyzes the synthesis of monounsaturated fatty acids [@pone.0064483-Dobrzyn1], this result indicates that AMDHD1 may be involved in fatty acid metabolism, which is one of the main functions of the liver.

PRUNE2 was previously studied in the central nervous system and in cancer patients, but there are no reports related to the function of PRUNE2 in the heart. GEO profiles provide some information to predict the function of PRUNE2 in the heart. The expression of PRUNE2 is decreased in ERRα (estrogen-related receptor alpha) deficient mouse hearts (GDS2727; [Figure 4B](#pone-0064483-g004){ref-type="fig"}; *P*\<0.01). ERRα regulates cellular energy metabolism, which is pivotal in high energy demand tissues such as the heart. The decreased expression of PRUNE2 in the heart of ERRα deficient mice indicates the function of PRUNE2 may be related to energy metabolism in the heart. Bonne et al. (1999) identified Lmna (lamin A/C) mutations in the autosomal dominant form of Emery--Dreifuss muscular dystrophy (AD-EDMD) [@pone.0064483-Bonne1]. The decreased expression of PRUNE2 in the Lmna H222P mutants (GDS 2746; [Figure 4C](#pone-0064483-g004){ref-type="fig"}; *P*\<0.05) suggests a relationship between PRUNE2 and Emery--Dreifuss muscular dystrophy. Patients with idiopathic dilated heart failure and ischemic heart failure have increased expression of PRUNE2, which also indicates a role of PRUNE2 in heart function (GDS651, [Figure 4D](#pone-0064483-g004){ref-type="fig"}; *P*\<0.05). PRUNE2 is also related to heart tension with higher expression in the heart of the hypertensive blood pressure high (BPH) inbred strains of mice and lower expression in genetically hypotensive blood pressure low (BPL) inbred strains compared to the normotensive blood pressure normal (BPN) inbred strains (GDS3673; [Figure 4E](#pone-0064483-g004){ref-type="fig"}; *P*\<0.05). All of these data suggest that PRUEN2 is related to heart function and heart disease.

ACVR1C, also named activin receptor-like kinase 7 (ALK7), has a known ligand, Nodal, and is one of the type I transforming growth factor-β (TGF-β) receptors [@pone.0064483-Roberts1]. GDS 3135 shows that, in fasted rats, the expression of ACVR1C increased significantly in both WAT and BAT ([Figure 5B](#pone-0064483-g005){ref-type="fig"}), suggesting a role for ACVR1C in releasing fats in both WAT and BAT. GDS3665 shows that the expression of ACVR1C is decreased significantly (*P*\<0.05; [Figure 5C](#pone-0064483-g005){ref-type="fig"}) in the adipose tissue from obese diabetic women compared to control women, which indicates that ACVR1C may be a contributing factor to obese diabetic symptoms.

ACVR1C is BAT and WAT-Specific {#s3c}
------------------------------

Given that average relative expression in other tissues such as liver, muscle, heart, lung, spleen, and kidney was approximately 1, the mRNA expression of ACVR1C in BAT and WAT was about 250-fold and 210-fold higher than in other tissues, respectively ([Figure 5A](#pone-0064483-g005){ref-type="fig"}). Therefore, ACVR1C showed significantly higher expression in both BAT and WAT. In addition, fractionation of SV cells and fat cells was verified by predominant expression of DLK1 (a preadipocyte marker) in SV cells (P\<0.01), and FABP4 and SCD1 (adipocyte markers) in fat cells (*P*\<0.05 and *P*\<0.01, respectively). In SV cells, mRNA expression of ACVR1C was significantly reduced. However, in fat cells, mRNA expression of ACVR1C was enhanced approximately 60-fold compared to expression in SV cells. Taken together, these results suggest that ACVR1C expression is specific to adipose tissue and adipocytes in the fat cell fraction.

Developmental Regulation of ACVR1C in 3T3-L1 Cells {#s3d}
--------------------------------------------------

Developmental regulation of gene expression of ACVR1C has been evaluated during adipogenic differentiation of 3T3-L1 preadipocytes ([Figure 5J](#pone-0064483-g005){ref-type="fig"}). The development of adipocytes was demonstrated by gradual increases in the expression of adipocyte markers, FABP4 and SCD1, during differentiation. In addition, expression of both FABP4 and SCD1 increased significantly after d 6 (*P*\<0.05). During 3T3-L1 preadipocyte differentiation, expression of ACVR1C showed a highly correlated pattern of expression to that of FABP4, with a significant increase at d 6 (*P*\<0.05).

Discussion {#s4}
==========

We have established a novel and powerful approach to predict tissue-specific genes. By comparing one human and one mouse GEO DataSet (GDS) from a microarray, we identified a total of 59 tissue-specific or tissue-related genes in the kidney, liver, lung, heart, muscle, and adipose tissue. After confirmation of the tissue-specific expression by semi-quantitative PCR, we searched for the functions of these genes in specific tissues using NCBI PubMed and GEO profiles to further support our approach. The following tissue-specific genes selected from a microarray were categorized as follows: i) Genes that are verified as tissue-specific in human in previous publications; ii) Genes that are verified as tissue-specific in mouse in previous publications; iii) Genes that are verified as tissue-specific in both human and mouse in previous publications; iv) Genes that are not confirmed as tissue-specific, but are said to contain tissue-related functions in previous publications; and v) Novel genes that have not been previously reported as tissue-specific or tissue-related, but are verified as tissue-specific by our PCR ([Table 14](#pone-0064483-t014){ref-type="table"}, [15](#pone-0064483-t015){ref-type="table"}, [16](#pone-0064483-t016){ref-type="table"}, [17](#pone-0064483-t017){ref-type="table"}, [18](#pone-0064483-t018){ref-type="table"}, [19](#pone-0064483-t019){ref-type="table"}).

10.1371/journal.pone.0064483.t014

###### Kidney-specific expression confirmed by publications and/or semi-quantitative PCR.

![](pone.0064483.t014){#pone-0064483-t014-14}

  Kidney                       Publicationin human                          Publicationin mouse        PCR
  --------- ---------------------------------------------------------- ------------------------------ -----
  GALNT11                  [@pone.0064483-Schwientek1]                  [@pone.0064483-Schwientek1]    --
  SLC22A6    [@pone.0064483-LopezNieto1], [@pone.0064483-Hosoyamada1]   [@pone.0064483-LopezNieto1]    --
  SLC22A8                      [@pone.0064483-Cha1]                        [@pone.0064483-Buist1]      --
  SLC22A2                     [@pone.0064483-Aoki1]                     [@pone.0064483-Mooslehner1]   
  KL                        [@pone.0064483-Matsumura1]                  [@pone.0064483-ShirakiIida1]   --
  PDZK1                                 --                                [@pone.0064483-Gisler1]       ○
  SLC12A3                  [@pone.0064483-Mastroianni1]                              --                 ○
  SPP1                                  --                                           --                 ○
  SLC34A1                               --                                           --                 ○
  FXYD2                                 --                                           --                 ○

10.1371/journal.pone.0064483.t015

###### Liver-specific expression confirmed by publications and/or semi-quantitative PCR.

![](pone.0064483.t015){#pone-0064483-t015-15}

  Liver        Publicationin human        Publicationin mouse      PCR  
  --------- -------------------------- -------------------------- ----- -------
  HAMP        [@pone.0064483-Park1]     [@pone.0064483-Pigeon1]    --   
  AHSG       [@pone.0064483-Denecke1]   [@pone.0064483-Denecke1]   --   
  AMBP                  --              [@pone.0064483-Salier1]     ○   
  HPX                   --                         --               ○   
  ALB                   --                         --               ○   
  APOA1                 --                         --               ○   
  SLC27A5               --                         --               ○   
  FGG                   --                         --               ○   
  GNMT                  --                         --               ○   
  MAT1A                 --                         --               ○   
  AMDHD1                --                         --               ○    Novel

10.1371/journal.pone.0064483.t016

###### Lung-specific expression confirmed by publications and/or semi-quantitative PCR.

![](pone.0064483.t016){#pone-0064483-t016-16}

  Lung          Publicationin human         Publicationin mouse       PCR
  --------- --------------------------- ---------------------------- -----
  CLDN5      [@pone.0064483-Sirotkin1]    [@pone.0064483-Morita1]     --
  CLDN18      [@pone.0064483-Niimi1]                 --               --
  LPCAT1     [@pone.0064483-Harayama1]   [@pone.0064483-Nakanishi1]   --
  MUC1          [@pone.0064483-Ho1]        [@pone.0064483-Braga1]     --
  SCGB1A1      [@pone.0064483-Peri1]                 --                ○
  SMAD6      [@pone.0064483-Imamura1]     [@pone.0064483-Imamura1]    --
  SFTPB                 --                           --                ○
  SFTPC                 --                           --                ○
  AGER                  --                           --                ○
  CLIC3                 --                           --                ○
  SLC34A2               --                           --                ○

10.1371/journal.pone.0064483.t017

###### Heart-specific expression confirmed by publications and/or semi-quantitative PCR.

![](pone.0064483.t017){#pone-0064483-t017-17}

  Heart      Publicationin human       Publicationin mouse      PCR  
  -------- ----------------------- --------------------------- ----- -------
  FHL2      [@pone.0064483-Chan1]     [@pone.0064483-Chu1]      --   
  HSPB7     [@pone.0064483-Vos1]    [@pone.0064483-Quraishe1]   --   
  MYOZ2     [@pone.0064483-Frey1]     [@pone.0064483-Frey1]     --   
  TNNT2              --                        --                ○   
  FHOD3              --                        --                ○   
  PLN                --                        --                ○   
  MYH6               --                        --                ○   
  CSRP3              --                        --                ○   
  NPPA               --                        --                ○   
  RYR2               --                        --                ○   
  PRUNE2             --                        --                ○    Novel

10.1371/journal.pone.0064483.t018

###### Muscle-specific expression confirmed by publications and/or semi-quantitative PCR.

![](pone.0064483.t018){#pone-0064483-t018-18}

  Muscle        Publicationin human          Publicationin mouse      PCR
  -------- ------------------------------ -------------------------- -----
  MYOT      [@pone.0064483-Salmikangas1]   [@pone.0064483-Mologni1]   --
  TNNC2                  --                           --               ○
  TNNI2                  --                           --               ○
  TNNT3                  --                           --               ○
  ACTN3                  --                           --               ○
  MYBPC1                 --                           --               ○
  MYBPC2                 --                           --               ○
  MYOZ1                  --                           --               ○

10.1371/journal.pone.0064483.t019

###### Adipose-specific expression confirmed by publications and/or semi-quantitative PCR.

![](pone.0064483.t019){#pone-0064483-t019-19}

  Adipose       Publicationin human                    Publicationin mouse                 PCR  
  --------- ---------------------------- ------------------------------------------------ ----- -------
  RETN         [@pone.0064483-Yang1]      [@pone.0064483-Steppan1], [@pone.0064483-Kim1]   --   
  ADIPOQ        [@pone.0064483-Hu1]                             --                         --   
  LEP           [@pone.0064483-Bi1]                   [@pone.0064483-Zhao1]                --   
  PPARγ      [@pone.0064483-VidalPuig1]               [@pone.0064483-Shin1]                --   
  CIDEC      [@pone.0064483-Magnusson1]                         --                          ○   
  CCDC80       [@pone.0064483-Okada1]                 [@pone.0064483-Okada1]               --   
  DGAT2        [@pone.0064483-Cases1]                 [@pone.0064483-Cases1]               --   
  ACVR1C                 --                                     --                          ○    Novel

Kidney-Specific Genes {#s4a}
---------------------

The 10 kidney-specific genes that we identified are GALNT11 ((UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 11), SLC22A6 \[solute carrier family 22 (organic anion transporter), member 6\], SLC22A8 \[solute carrier family 22 (organic anion transporter), member 8\], SLC22A2 \[solute carrier family 22 (organic cation transporter), member 2\], KL (klotho), PDZK1 (PDZ domain containing 1), SLC12A3 \[solute carrier family 12 (organic cation transporter), member 3\], SPP1 (secreted phosphoprotein 1), SLC34A1 \[solute carrier family 34 (sodium phosphate), member 1\], and FXYD2 (FXYD domain containing ion transport regulator 2). Among them, genes that have been verified by publications for the human and/or mouse include GALNT11 [@pone.0064483-Schwientek1], SLC22A6 [@pone.0064483-LopezNieto1], [@pone.0064483-Hosoyamada1], SLC22A8 [@pone.0064483-Cha1], [@pone.0064483-Buist1], SLC22A2 [@pone.0064483-Aoki1], [@pone.0064483-Mooslehner1], KL [@pone.0064483-Matsumura1], [@pone.0064483-ShirakiIida1], PDZK1 [@pone.0064483-Gisler1], and SLC12A3 [@pone.0064483-Mastroianni1]. Genes confirmed by PCR include SLC22A2, PDZK1, SLC12A3, SPP1, SLC34A1, and FXYD2.

The SLC genes belong to the solute carrier family. The SLC22A2, SLC22A6, and SLC22A8 genes are members of the organic anion transporter SLC22 gene family [@pone.0064483-Koepsell1]. SLC12A3 belongs to an electroneutral cation-chloride-coupled cotransporter gene family. SLC34A1 is a member of the type II sodium-phosphate co-transporter family. All of these genes are responsible for solute (organic anion, sodium/chloride, and phosphate, respectively) transportation in the kidney, which is the key aspect for kidney function.

KL is a single transmembrane protein that is mainly produced in the kidney and brain. Severely reduced production of KL can induce chronic renal failure in the human kidney [@pone.0064483-Koh1]. FXYD2 is the gamma subunit of the Na,K-ATPase and functions in regulating the enzyme's activity by inducing ion channel activity. Mutations in this gene have been associated with renal hypomagnesaemia [@pone.0064483-Sha1]. SPP1 is synthesized by the kidney and secreted into the urine by epithelial cells [@pone.0064483-Hudkins1]. It functions to inhibit the nucleation and aggregation of calcium oxalate crystals [@pone.0064483-Grover1]. PDZK1 is a scaffold protein that is located in brush borders of proximal tubular cells [@pone.0064483-Gisler1]. PDZK1 binds to and mediates the localization of cell surface proteins and plays an important role in cholesterol metabolism [@pone.0064483-Komori1]. GALNT11 is an enzyme that is highly expressed in the kidney and catalyzes O-linked oligosaccharide biosynthesis and transfers N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor.

Liver-Specific Genes {#s4b}
--------------------

HAMP (hepcidin antimicrobial peptide), AHSG (alpha-2-HS-glycoprotein), AMBP (alpha-1-microglobulin/bikunin precursor), HPX (hemopexin), ALB(albumin), APOA1 (apolipoprotein A-I), SLC27A5 \[solute carrier family 27 (fatty acid transporter), member 5\], FGG (fibrinogen gamma chain), GNMT (glycine N-methyltransferase), MAT1A (methionine adenosyltransferase I, alpha), and AMDHD1 (amidohydrolase domain containing 1) exhibit significantly higher expression in liver than in other tissues. The liver-specific expressions of HAMP [@pone.0064483-Park1], [@pone.0064483-Pigeon1], AHSG [@pone.0064483-Denecke1], and AMBP [@pone.0064483-Salier1] in human and/or mouse were confirmed by previous publications. AMBP, HPX, ALB, APOA1, SLC27A5, FGG, GNMT, and MAT1A were confirmed as liver-specific by semi-quantitative PCR.

HAMP functions in the maintenance of iron homeostasis, and is required for intestinal iron absorption and iron storage in macrophages. Mutations in this gene may cause hemochromatosis type 2B, which is an endocrine liver disease. HPX is a plasma glycoprotein that can bind and transport heme from the plasma to the liver for iron recovery to prevent heme-mediated oxidative damage and heme-bound iron loss [@pone.0064483-Tolosano1]. AHSG and ALB are both synthesized by hepatocytes and secreted to the serum. AHSG is involved in ectopic calcium deposition [@pone.0064483-Wang1], insulin resistance [@pone.0064483-Srinivas1], [@pone.0064483-Rauth1], and fat accumulation in the liver [@pone.0064483-Stefan1]. ALB composes about half of the blood serum protein. It serves as a carrier for steroids, fatty acids, thyroid hormones, and drugs and as a regulator for the colloidal osmotic pressure of blood. ALB levels are decreased in chronic liver disease and nephrotic syndrome.

AMBP is a liver-specific precursor protein of alpha-1-microglobulin and bikunin. Alpha-1-microglobulin belongs to the lipocalin transport protein superfamily and functions in inflammatory processes, whereas bikunin is a urinary trypsin inhibitor. FGG is a blood-borne glycoprotein that can be cleaved by thrombin to form fibrin and act as a co-factor in platelet aggregation. Defects in this gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, and thrombophilia. APOA1 is the main component of high density lipoprotein (HDL) in blood plasma. It promotes reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues [@pone.0064483-Johnson1]. SLC27A5, GNMT, and MATA1A have enzymatic activities. SLC27A5 is a fatty acid transporter, and encodes Acyl-CoA synthetase, which is involved in bile acid metabolism in the liver. GNMT catalyzes the conversion of S-adenosyl-methionine (SAM) to S-adenosylhomocysteine and sarcosine. MAT1A catalyzes the formation of S-adenosylmethionine from methionine and ATP. All of these activities occur predominantly in the liver and are important for normal liver functions.

AMDHD1 is only contained in mouse GDS and is highly ranked, indicating its liver-specific expression. Human GDS596 only contains data for about 22,000 spots, whereas the mouse GDS3142 has data for more than 45,000 spots. Searching for "AMDHD1 liver" in NCBI PubMed (<http://www.ncbi.nlm.nih.gov/pubmed>) returns no results. Searching GEO profiles provides indications about the function of AMDHD1 in the liver. AMDHD1 protein contains 426 amino acids and has been reported to be involved in the histidine metabolism pathway [@pone.0064483-Assi1]. The expression of AMDHD1 in the liver is inhibited by microRNA miR-122 antisense. The miR-122 makes up 70% of all microRNA in the adult liver. It is highly expressed in the developing and adult liver [@pone.0064483-Chang1]. It negatively regulates target mRNAs and is thought to be important for establishing tissue-specific gene expression patterns. The expression of AMDHD1 is negatively regulated by miR-122 in the liver, suggesting that AMDHD1 may be involved in liver development and formation. AMDHD1 does not have miR-122 binding sites ([www.microrna.org](http://www.microrna.org)), which indicates that miR-122 is a *trans*-acting factor for AMDHD1. HNF4α is a nuclear receptor that can activate the expression of hundreds of genes in the liver, especially metabolism-related genes in glucose, fatty acid, cholesterol, and drug metabolism [@pone.0064483-Odom1], [@pone.0064483-Waxman1]. The HNF4α null mice are embryonic lethal [@pone.0064483-Chen1]. The decreased expression of AMDHD1 in HNF4α deleted liver suggests that AMDHD1 is involved in hepatogenesis. GDS2577 shows that expression of AMDHD1 is significantly higher in the regenerating liver than in the developing liver, which suggests a function for AMDHD1 in renewal and repair of the liver.

SCD1 is an enzyme that is responsible for forming a double bond in stearoyl-CoA to form monounsaturated fatty acid from saturated fatty acid [@pone.0064483-Dobrzyn1]. A low fat, high carbohydrate diet may cause SCD1 null mice to develop severe hypercholesterolemia. The significantly lower expression of AMDHD1 in the low fat, high carbohydrate treated SCD1 null mice (GDS-1517) indicates that AMDHD1 is involved in fatty acid metabolism in the liver.

Lung-Specific Genes {#s4c}
-------------------

Lung-specific genes identified in the current study include LPCAT1 (lysophosphatidylcholine acyltransferase 1), MUC1 (mucin 1, cell surface associated), SCGB1A1 \[secretoglobin, family 1A, member 1 (uteroglobin)\], SFTPB (surfactant protein B), SFTPC (surfactant protein C), AGER (advanced glycosylation end product-specific receptor), CLDN5 (claudin 5), CLDN18 (claudin 18), SLC34A2 \[solute carrier family 34 (sodium phosphate), member 2\], SMAD6 (SMAD family member 6), and CLIC3 (chloride intracellular channel 3). Among them, lung-specific expression in human and/or mouse was either confirmed by publications {CLDN5 [@pone.0064483-Sirotkin1], [@pone.0064483-Morita1], CLDN18 [@pone.0064483-Niimi1], LPCAT1 [@pone.0064483-Harayama1], [@pone.0064483-Nakanishi1], MUC1 [@pone.0064483-Ho1], [@pone.0064483-Braga1], SCGB1A1 [@pone.0064483-Peri1], and SMAD6 [@pone.0064483-Imamura1]} or PCR (SCGB1A1, SFTPB, SFTPC, AGER, SLC34A2, and CLIC3).

Bridges et al. (2010) reported that LPCAT1 functions in surfactant phospholipid synthesis and is essential for transitioning to air breathing in neonatal mice [@pone.0064483-Bridges1]. MUC1 serves as a protective layer in the airway against bacterial and enzyme attack. SCGB1A1 is an anti-inflammatory agent that decreases systemic inflammation and increases surfactant protein and vascular endothelial growth factor expression. It functions in reducing lung injury, improves pulmonary compliance and oxygenation. SFTPB and SFTPC are both expressed on the pulmonary surfactant to promote alveolar stability by reducing air-liquid interface tension.

The CLDNs are located on tight junction strands on the cell membrane of the lung and serve as a physical barrier for solutions and water. Mutations in CLDN5 may cause velocardiofacial syndrome [@pone.0064483-Sirotkin1], whereas mutations in CLDN18 are related to lung adenocarcinomas [@pone.0064483-Merikallio1]. AGER is highly expressed in the embryonic brain and adult lung. AGER expression is significantly decreased in human lung carcinomas, which suggests that AGER may function in suppressing lung cancer. SLC34A2 is a phosphate transport protein. Mutations in SLC34A2 may cause pulmonary alveolar microlithiasis [@pone.0064483-Tachibana1].

SMAD6 inhibits transforming growth factor-beta (TGF-β) superfamily-regulated cell growth and development. CLIC3 is a component of chloride ion channels. The functions of these two genes are understudied in the lung. By searching the GEO profile, we predict that SMAD6 and CLIC3 could be related to idiopathic pulmonary fibrosis and pulmonary adenocarcinomas. Compared to the normal lung tissue, the expressions of SMAD6 and CLIC3 are lower in tissues with idiopathic pulmonary fibrosis (GDS1252) and pulmonary adenocarcinoma (GDS1650 and GDS 3257).

Heart-Specific Genes {#s4d}
--------------------

In the heart, FHL2 (four and a half LIM domains 2), HSPB7 \[heat shock 27 kDa protein family, member 7 (cardiovascular)\], MYOZ2 (myozenin 2), FHOD3 (formin homology 2 domain containing 3), PLN (phospholamban), MYH6 (myosin, heavy chain 6, cardiac muscle, alpha), CSRP3 \[cysteine and glycine-rich protein 3 (cardiac LIM protein)\], NPPA (natriuretic peptide A), RYR2 (ryanodine receptor 2, cardiac), TNNT2 (troponin T type 2, cardiac), and PRUNE2 have significantly higher expressions compared to other tissues. Publications confirmed the human and/or mouse heart-specific expression of FHL2 [@pone.0064483-Chan1], [@pone.0064483-Chu1], HSPB7 [@pone.0064483-Vos1], [@pone.0064483-Quraishe1], and MYOZ2 [@pone.0064483-Frey1], and PCR confirmed the heart specific expression of TNNT2, FHOD3, PLN, MYH6, CSRP3, NPPA, RYR2, and PRUNE2.

FHL2 functions in many fundamental processes by interacting with a variety of types of proteins including structural proteins, kinases, and transcription factors. HSPB7 interacts with alpha filamin, and is potentially involved in chaperone activity and maintenance of the cytoskeletal network in the cardiac muscle. MYOZ may serve as intracellular binding proteins involved in linking Z line proteins and localizing calcineurin signaling to the sarcomere. FHOD3 is an actin-organizing protein that may regulate stress fiber formation. PLN has been postulated to regulate the activity of the calcium pump of the cardiac sarcoplasmic reticulum. CSRP3 is an organizer of cytosolic structures in cardiomyocytes. Mutations in this gene may cause hypertrophic cardiomyopathy and dilated cardiomyopathy in humans [@pone.0064483-Geier1]. NPPA is a hormone playing a key role in cardiovascular homeostasis. Both MYH6 and RYR2 are responsible for cardiac muscle contraction. RYR2 mutations may cause catecholaminergic polymorphic ventricular tachycardia (CPVT) and arrhythmogenic right ventricular dysplasia (ARVD) [@pone.0064483-Priori1], [@pone.0064483-Tiso1].

Full length PRUNE2 contains 3,088 amino acids, which can be divided into 19 exons. PRUNE2 has 5 isoforms: BMCC1 \[Bcl-2/adenovirusE1B 19 kDa-interacting protein (BNIP) 2 and Cdc42 GAP homology (BCH) motif-containing molecule at the C-terminal region1\], BNIPXL (BNIP2 extralong), C9orf65 (Chromosome 9 Open Reading Frame 65), PRUNE2, and Olfaxin. BMCC1 is associated with neuronal apoptosis [@pone.0064483-Machida1], BNIPXL is an N-terminal truncated form of BMCC1 and is related to cellular transformation [@pone.0064483-Soh1], C9orf65 is a biomarker that distinguishes leiomyosarcomas from gastrointestinal stromal tumors [@pone.0064483-Price1], PRUNE2 is a binding protein of 8-oxo-GTP that contains C9orf65 and BMCC1 [@pone.0064483-Clarke1], [@pone.0064483-Iwama1]. These four PRUNE2 isoforms may play crucial roles in Alzheimer's disease and cancer. Olfaxin is the most recently discovered PRUNE2 isoform that is located in the olfactory systems [@pone.0064483-Li3].

Neuronal tissues were not included in our samples. The expression of PRUNE2 was significantly greater in the heart compared to other tissues in the mouse (*P*\<0.001) but not human (*P*\<0.5) Searching NCBI PubMed returned no publications about PRUNE2 in the heart. However, our semi-quantitative and real-time quantitative PCR confirmed the high expression of PRUNE2 in both human and mouse heart.

From GEO profiles we found that expression of PRUNE2 is decreased in ERRα-deficient mouse hearts. Considering ERRα is an orphan nuclear receptor that plays a critical role in regulating cellular energy metabolism, the decreased expression of PRUNE2 in ERRα-deficient mouse hearts suggests that PRUNE2 may be involved in energy metabolism in the mouse heart.

PRUNE2 is likely to be related to heart diseases. The expression of PRUNE2 is decreased in Lmna H222P mutants, which in turn are related to Emery--Dreifuss muscular dystrophy [@pone.0064483-Bonne1]. These results suggest an association between PRUNE2 and Emery--Dreifuss muscular dystrophy.

The function of PRUNE2 in cardiomyocyte diseases is linked to serum response factor (SRF). SRF plays a critical role in mesodermal development [@pone.0064483-Arsenian1] and the deletion of SRF causes embryonic lethal cardiovascular phenotypes. Expression of PRUNE2 is upregulated in SRF-null mutants, which indicates that PRUNE2 may be associated with cardiomyocyte diseases. Increased expression of PRUNE2 is also found in patients with idopathic dilated heart failure and ischemic heart failure, which supports the role of PRUNE2 in heart function. PRUNE2 expression is the highest in the hearts of genetically hypertensive BPH inbred strains of mice compared to the normotensive BPN and hypotensive BPL inbred strains. All of these data suggest an important role for PRUNE2 in heart function and heart diseases.

Muscle-Specific Genes {#s4e}
---------------------

All 8 of the muscle specific genes we identified are well-studied for their roles in muscle function: MYOT (myotilin), TNNC2 (troponin C type 2, fast), TNNI2 (troponin I type 2, skeletal, fast), TNNT3 (troponin T type 3, skeletal, fast), MYBPC1 (myosin binding protein C, slow type), MYOZ1 (myozenin 1), ACTN3 (actinin, alpha 3), and MYBPC2 (myosin binding protein C, fast type). We confirmed the muscle-specific expression of TNNC2, TNNI2, TNNT3, ACTN3, MYBPC1, MYBPC2, and MYOZ1 by PCR and two publications supported the muscle-specific expression of MYOT [@pone.0064483-Salmikangas1], [@pone.0064483-Mologni1].

MYOT is located within the Z-disc of sarcomeres. Mutations in the MYOT gene cause various forms of muscular dystrophy [@pone.0064483-Hauser1], [@pone.0064483-Selcen1], [@pone.0064483-Foroud1], [@pone.0064483-PnissonBesnier1]. Troponin is a key protein controlling striated muscle contraction. It is composed of 3 subunits: the TNNI subunit inhibits actomyosin ATPase, the TNNC subunit binds to calcium and overcomes the inhibitory action of the troponin complex on actin filaments, and the TNNT subunit binds to tropomyosin and TNNC. TNNI2, TNNC2, and TNNT3 are specifically expressed in muscle, whereas TNNT2 is mainly expressed in cardiac muscle. MYBPC1 and MYBPC2 are skeletal muscle slow-twitch and fast-twitch myosin binding proteins, which can regulate the activity of actin-activated myosin ATPase to modulate muscle contraction. MYOZ1 functions in modulating calcineurin signaling in skeletal muscle.

Adipose-Specific Genes {#s4f}
----------------------

Six genes that were confirmed by publications to be highly expressed in human and mouse adipose tissue are: RETN (resistin) [@pone.0064483-Yang1], [@pone.0064483-Steppan1], [@pone.0064483-Kim1], ADIPOQ (adiponectin, C1Q and collagen domain containing) [@pone.0064483-Hu1], LEP (leptin) [@pone.0064483-Bi1], [@pone.0064483-Zhao1], PPARγ (peroxisome proliferator-activated receptor gamma) [@pone.0064483-VidalPuig1], [@pone.0064483-Shin1], CIDEC (Cell death--inducing DFF45-like effector C) [@pone.0064483-Magnusson1], CCDC80 (coiled-coil domain containing 80) [@pone.0064483-Okada1], and DGAT2 (diacylglycerol O-acyltransferase 2) [@pone.0064483-Cases1]. Our PCR data showed the adipose specific expression of CIDEC (cell death-inducing DFFA-like effector c) and ACVR1C.

Both RETN and ADIPOQ are adipokines that control insulin sensitivity and fat metabolism. LEP controls the size of adipose depots by affecting food intake and energy expenditure. PPARγ is a well-known regulator of adipocyte differentiation, glucose hemeostasis, and blood pressure. CIDEC is localized around the lipid droplet in adipocytes and regulates lipid droplet formation [@pone.0064483-Puri1], [@pone.0064483-Keller1]. It can regulate energy balance and obesity [@pone.0064483-Nishino1] and induce cell apoptosis [@pone.0064483-Liang1]. CCDC80 is a secreted protein that regulates adipocyte differentiation [@pone.0064483-Tremblay1], whereas DGAT2 is an enzyme that catalyzes the final step of mammalian triglyceride synthesis [@pone.0064483-Chen2] and may be involved in the mechanisms of obesity, insulin resistance, and leptin resistance.

Our SV and fat cell fractionation studies showed that ACVR1C is adipocyte-specific, but not preadipocyte-specific. ACVR1C was further confirmed to be both WAT-specific and BAT-specific. When fasted, the expression of ACVR1C increases significantly in rat WAT and BAT, which suggests a role for ACVR1C in fat metabolism. In the adipose tissue from obese diabetic women, the expression of ACVR1C is decreased significantly, which suggests a role for ACVR1C in obese diabetic symptoms.

In summary, our approach provides a new and powerful procedure to discover novel tissue-specific genes and predict the processes or pathways in which they may be involved. With this method, we discovered novel tissue-specific genes: AMDHD1 in the liver, PRUNE2 in the heart, and ACVR1C in the adipose tissue. Our procedure also can be extended to other tissues in other species. This approach is an efficient way of integrating valuable databases to identify novel sets of tissue-specific genes that are related to tissue growth and development, and diseases.

Supporting Information {#s5}
======================

###### 

**Tissue-specific gene expression values based on GEO DataSet(GDS)596 for the human and GDS3142 for the mouse.** The microarray gene expression profiles for the six tissues (kidney, liver, lung, heart, muscle, and adipose tissue) of the human and mouse were collected from GEO DataSet(GDS) in the National Center for Biotechnology Information (NCBI) web page. \*Average gene expression values for each tissue including a target tissue were obtained. \*\*Those average values for each tissue were divided by an average value of a target tissue and then averaged for obtaining one representative value. If the representative value is lower, then tissue-specificity for a target tissue is higher because it was divided by an average value of a target tissue. \*\*\*An alternative approach shows that an average value of a target tissue was divided by average of averages for each tissue. If the result value is higher, then tissue-specificity for a target tissue is higher because an average value of a target tissue was divided. [Figure 1](#pone-0064483-g001){ref-type="fig"} shows the schematic diagram for the above procedures.
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Click here for additional data file.
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